Evidence map›Paper›PMID 35017935›Full record

ArticleJournal of pharmacy & bioallied sciences2021

Evaluation of

Lopamudra Das, Ashok Kumar Panigrahi, Sashi Bhusan Biswal, Debasis Bisoi

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of pharmacy & bioallied sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Lopamudra DasDepartment of Botany, J.K.B.K. Government College, Cuttack, Odisha, India.
Ashok Kumar PanigrahiDepartment of Pharmacology, V.S.S. Institute of Medical Sciences and Research, Sambalpur, Odisha, India.
Sashi Bhusan BiswalDepartment of Pharmacology, V.S.S. Institute of Medical Sciences and Research, Sambalpur, Odisha, India.
Debasis BisoiDepartment of Pharmacology, AIIMS, Bibinagar, Telangana, India.
Shamnur Shivashankarappa Institute of Medical Sciences & Research Centre · INAll India Institute of Medical Sciences Bhopal · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

aimsThe aim of this study was to validate the ethnobotanical uses of the antimalarial activity of leaves of NAT by MATERIALS AND

methodsLeaves of NAT were identified and authenticated and phytoconstituents of NAT were identified. The antimalarial activity of NAT was studied in STATISTICAL ANALYSIS USED: One-way ANOVA was done for comparison of different groups followed by

resultsThe mean schizonticidal activity of NAT increased from 14.21 to 46.15 (

conclusionsThe antiplasmodial activity of NAT might be like that of artemisinin by producing oxidative stress mostly due to the iridoid glycosides. The active phytoconstituent(s) responsible may be tested individually or in combination both by

Indexed as

Iridoid glycosidesmalarianight jasmineNyctanthes arbor-tristisoxidative stress

Identifiers

PMID35017935
PMCPMC8686946
OpenAlexW3212636898

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.